The MDC Mission

The Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC) carries out basic biomedical research with the aim of understanding the molecular basis of health and disease, and translating these findings as quickly as possible into clinical application. The research involves the diagnosis and treatment of diseases, as well as their prevention.

MDC 25 years

Research Highlights

Algorithms help navigate through the data thicket of biological systems

If one looks beyond individual molecules, biology quickly becomes complex. Computer scientist Uwe Ohler are using algorithms and mathematical models to map a path through this tangle of dependencies.


Breaking the bonds of pain

Slightest touch can evoke pain in patients suffering from nerve injuries. Researchers of the MDC now have suppressed this type of neuropathic pain in mice by applying a chemical substance to the skin. The method could work in humans.


Further research highlights


“The MDC will still be a flourishing center”

On this day 25 years ago, the MDC was officially named after the geneticist Max Delbrück. Many things have changed since then. The MDC's Director Martin Lohse looks forward into the future: What will the research center look like in 2042?


Two Humboldt award winners are coming to the MDC as visiting scientists

David H. Gutmann, the US neurologist, and Prof. Maike Sander, a diabetes researcher at the University of California, San Diego, USA, have now been granted the Humboldt Research Award by the Alexander von Humboldt Foundation.


MDC alumnus Yves Muller: Crystal clear advice for postdocs

“Ideally as a postdoc you should aim to publish as last as well as first author and gather experience writing grants,” says Professor Yves Muller. The crystallographer emphasises that postdocs wanting to become group leads need to enjoy independence and be ready to follow their own ideas.


Further news on MDC Insights